Component

Allopurinol

Study-scoped entity; inspect species, exposure, model and limitations on each claim.

6 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Allopurinol prevented the fructose-associated increase in 24-hour diastolic and daytime systolic/diastolic blood pressure.

    Allopurinol → Human ambulatory blood pressure during experimental fructose loading source_derived_draftungraded
    Experimental context and source evidence
    dose
    200 g fructose/day with or without allopurinol; drug dose not recovered in accessed abstract
    duration
    2 weeks
    evidence_access
    Primary abstract/metadata; unrecovered methods explicitly retained.
    evidence_scope
    literature_reviewed; source-specific curation
    experimental_model
    74 adult men in randomized fructose-loading intervention
    exposure_scope
    Isolated fructose / drug perturbation
    limitations
    Very high pure-fructose dose; allopurinol did not correct every outcome. Pharmacological rescue does not prove sole mediation by urate or justify treatment of ordinary HFCS intake.
    nutrient_topic
    HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
    organism
    74 adult men in randomized fructose-loading intervention
    plain_language
    Allopurinol prevented the fructose-associated increase in 24-hour diastolic and daytime systolic/diastolic blood pressure.
    primary_references
    Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. (2010). https://pubmed.ncbi.nlm.nih.gov/20029377/ DOI: 10.1038/ijo.2009.259
    route
    Oral fructose and oral drug
    tissue
    Urate, ambulatory blood pressure and metabolic markers

    High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 545–555

    Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · 74 adult men in randomized fructose-loading intervention · source_derived_draft · unverified_draft

    ## hfcs-allopurinol-bp Allopurinol prevented the fructose-associated increase in 24-hour diastolic and daytime systolic/diastolic blood pressure. Model/species: 74 adult men in randomized fructose-loading intervention Tissue: Urate, ambulatory blood pressure and metabolic markers Exposure: 200 g fructose/day with or without allopurinol; drug dose not recovered in accessed abstract Route: Oral fructose and oral drug Duration: 2 weeks Exposure scope: Isolated fructose / drug perturbation Limits: Very high pure-fructose dose; allopurinol did not correct every outcome. Pharmacological rescue does not prove sole mediation by urate or justify treatment of ordinary HFCS intake. Reference: Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. (2010). https://pubmed.ncbi.nlm.nih.gov/20029377/ DOI: 10.1038/ijo.2009.259 Access: Primary abstract/metadata; unrecovered methods explicitly retained.
    Complete structured claim and evidence

  2. Allopurinol did not reduce the HOMA insulin-resistance index during the fructose-loading trial.

    Allopurinol → Human HOMA insulin-resistance index during fructose loading source_derived_draftungraded
    Experimental context and source evidence
    dose
    200 g fructose/day with or without allopurinol; drug dose not recovered in accessed abstract
    duration
    2 weeks
    evidence_access
    Primary abstract/metadata; unrecovered methods explicitly retained.
    evidence_scope
    literature_reviewed; source-specific curation
    experimental_model
    74 adult men in randomized fructose-loading intervention
    exposure_scope
    Isolated fructose / drug perturbation
    limitations
    Very high pure-fructose dose; allopurinol did not correct every outcome. Pharmacological rescue does not prove sole mediation by urate or justify treatment of ordinary HFCS intake.
    nutrient_topic
    HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
    organism
    74 adult men in randomized fructose-loading intervention
    plain_language
    Allopurinol did not reduce the HOMA insulin-resistance index during the fructose-loading trial.
    primary_references
    Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. (2010). https://pubmed.ncbi.nlm.nih.gov/20029377/ DOI: 10.1038/ijo.2009.259
    route
    Oral fructose and oral drug
    tissue
    Urate, ambulatory blood pressure and metabolic markers

    High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 557–567

    Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · 74 adult men in randomized fructose-loading intervention · source_derived_draft · unverified_draft

    ## hfcs-allopurinol-homa-null Allopurinol did not reduce the HOMA insulin-resistance index during the fructose-loading trial. Model/species: 74 adult men in randomized fructose-loading intervention Tissue: Urate, ambulatory blood pressure and metabolic markers Exposure: 200 g fructose/day with or without allopurinol; drug dose not recovered in accessed abstract Route: Oral fructose and oral drug Duration: 2 weeks Exposure scope: Isolated fructose / drug perturbation Limits: Very high pure-fructose dose; allopurinol did not correct every outcome. Pharmacological rescue does not prove sole mediation by urate or justify treatment of ordinary HFCS intake. Reference: Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. (2010). https://pubmed.ncbi.nlm.nih.gov/20029377/ DOI: 10.1038/ijo.2009.259 Access: Primary abstract/metadata; unrecovered methods explicitly retained.
    Complete structured claim and evidence

  3. Allopurinol lowered serum urate during the high-dose fructose intervention.

    Allopurinol → Human plasma urate concentration source_derived_draftungraded
    Experimental context and source evidence
    dose
    200 g fructose/day with or without allopurinol; drug dose not recovered in accessed abstract
    duration
    2 weeks
    evidence_access
    Primary abstract/metadata; unrecovered methods explicitly retained.
    evidence_scope
    literature_reviewed; source-specific curation
    experimental_model
    74 adult men in randomized fructose-loading intervention
    exposure_scope
    Isolated fructose / drug perturbation
    limitations
    Very high pure-fructose dose; allopurinol did not correct every outcome. Pharmacological rescue does not prove sole mediation by urate or justify treatment of ordinary HFCS intake.
    nutrient_topic
    HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
    organism
    74 adult men in randomized fructose-loading intervention
    plain_language
    Allopurinol lowered serum urate during the high-dose fructose intervention.
    primary_references
    Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. (2010). https://pubmed.ncbi.nlm.nih.gov/20029377/ DOI: 10.1038/ijo.2009.259
    route
    Oral fructose and oral drug
    tissue
    Urate, ambulatory blood pressure and metabolic markers

    High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 533–543

    Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · 74 adult men in randomized fructose-loading intervention · source_derived_draft · unverified_draft

    ## hfcs-allopurinol-urate Allopurinol lowered serum urate during the high-dose fructose intervention. Model/species: 74 adult men in randomized fructose-loading intervention Tissue: Urate, ambulatory blood pressure and metabolic markers Exposure: 200 g fructose/day with or without allopurinol; drug dose not recovered in accessed abstract Route: Oral fructose and oral drug Duration: 2 weeks Exposure scope: Isolated fructose / drug perturbation Limits: Very high pure-fructose dose; allopurinol did not correct every outcome. Pharmacological rescue does not prove sole mediation by urate or justify treatment of ordinary HFCS intake. Reference: Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. (2010). https://pubmed.ncbi.nlm.nih.gov/20029377/ DOI: 10.1038/ijo.2009.259 Access: Primary abstract/metadata; unrecovered methods explicitly retained.
    Complete structured claim and evidence

  4. The NAT2 ratio AFMU/1MX fell to 56.7%, an alternative combined-metabolite NAT2 ratio stayed constant, and a CYP1A2 ratio transiently rose to 167%.

    Allopurinol → Caffeine-derived urinary enzyme-phenotyping ratios source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Same 21-person caffeine-phenotyping study.
    limitations
    Changed ratios do not prove corresponding changes in NAT2 or CYP1A2 catalytic activity.
    nutrient_topic
    Caffeine collection; salts, coffee, species and coexposure contexts retain their identities. · Caffeine
    plain_language
    A downstream block can make another enzyme’s probe result misleading.
    primary_references
    Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569

    Caffeine: receptors, metabolism, nutrient interactions, adaptation and discovery questions (2026-09-18) · lines 244–250

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Same 21-person caffeine-phenotyping study. · source_derived_draft · unverified_draft

    ## caf-probe-confounding A downstream block can make another enzyme’s probe result misleading. The NAT2 ratio AFMU/1MX fell to 56.7%, an alternative combined-metabolite NAT2 ratio stayed constant, and a CYP1A2 ratio transiently rose to 167%. Model: Same 21-person caffeine-phenotyping study. Limitations: Changed ratios do not prove corresponding changes in NAT2 or CYP1A2 catalytic activity. Evidence access: Primary abstract Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569
    Complete structured claim and evidence

  5. In 21 participants, allopurinol reduced urinary 1-methyluric-acid/1-methylxanthine to 15.9% of baseline.

    Allopurinol → Caffeine-derived urinary enzyme-phenotyping ratios source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    200 mg caffeine tests during allopurinol 300 mg/day for eight days.
    limitations
    The ratio is a context-dependent probe, not a direct measurement of dietary molybdenum.
    nutrient_topic
    Caffeine collection; salts, coffee, species and coexposure contexts retain their identities. · Caffeine
    plain_language
    Blocking a downstream enzyme changed the metabolite pattern.
    primary_references
    Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569

    Caffeine: receptors, metabolism, nutrient interactions, adaptation and discovery questions (2026-09-18) · lines 236–242

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · 200 mg caffeine tests during allopurinol 300 mg/day for eight days. · source_derived_draft · unverified_draft

    ## caf-xor-ratio Blocking a downstream enzyme changed the metabolite pattern. In 21 participants, allopurinol reduced urinary 1-methyluric-acid/1-methylxanthine to 15.9% of baseline. Model: 200 mg caffeine tests during allopurinol 300 mg/day for eight days. Limitations: The ratio is a context-dependent probe, not a direct measurement of dietary molybdenum. Evidence access: Primary abstract Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10027663/ · DOI 10.1007/s002280050569
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Allopurinol specifically and dose-dependently inhibited conversion of caffeine-derived 1-methylxanthine to 1-methyluric acid.

    1-Methylxanthine → 1-Methyluric acid source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Two healthy nonsmokers; caffeine 5 mg/kg before/during allopurinol 300 or 600 mg/day.
    limitations
    Very small human mechanistic study; not proof that dietary molybdenum controls parent-caffeine clearance.
    nutrient_topic
    Caffeine collection; salts, coffee, species and coexposure contexts retain their identities. · Caffeine
    plain_language
    A later caffeine metabolite uses the xanthine-oxidoreductase pathway.
    primary_references
    Effect of allopurinol on caffeine disposition in man. · 1986 · https://pubmed.ncbi.nlm.nih.gov/3754760/ · DOI 10.1111/j.1365-2125.1986.tb05222.x

    Caffeine: receptors, metabolism, nutrient interactions, adaptation and discovery questions (2026-09-18) · lines 228–234

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Two healthy nonsmokers; caffeine 5 mg/kg before/during allopurinol 300 or 600 mg/day. · source_derived_draft · unverified_draft

    ## caf-xor-product A later caffeine metabolite uses the xanthine-oxidoreductase pathway. Allopurinol specifically and dose-dependently inhibited conversion of caffeine-derived 1-methylxanthine to 1-methyluric acid. Model: Two healthy nonsmokers; caffeine 5 mg/kg before/during allopurinol 300 or 600 mg/day. Limitations: Very small human mechanistic study; not proof that dietary molybdenum controls parent-caffeine clearance. Evidence access: Primary abstract Effect of allopurinol on caffeine disposition in man. · 1986 · https://pubmed.ncbi.nlm.nih.gov/3754760/ · DOI 10.1111/j.1365-2125.1986.tb05222.x
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards